LGBT Cancer Project

Therapeutic Areas: Oncology | Nephrology | Family Medicine | Urology

Bladder Cancer Clinical Trials

A listing of Bladder Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Phoenix Arizona 85004

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

UPDATED

Tucson Arizona 85711

A clinical research study of pembrolizumab for the treatment of Bladder Cancer, High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

California

UPDATED

Duarte California 91010

A clinical research study of pembrolizumab for the treatment of Bladder Cancer, High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study evaluating B-701, Docetaxel and placebo for the treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma, Urinary Bladder Disease or Urological Diseases

UPDATED

Duarte California 91010

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

UPDATED

Los Agneles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90048

A clinical research study of pembrolizumab for the treatment of Bladder Cancer, High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

UPDATED

Los Angeles California 90025

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90095

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90095-6984

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90095

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90024

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Newport Beach California 92663

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Orange California 92868

A clinical research study of pembrolizumab for the treatment of Bladder Cancer, High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

UPDATED

Santa Monica California 90404

A clinical research study of pembrolizumab for the treatment of Bladder Cancer, High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

UPDATED

Santa Monica California 90404

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Santa Monica California 90403

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Santa Monica California 90404

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Connecticut

UPDATED

Farmington Connecticut 06030-2205

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Farmington Connecticut 06030

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

District of Columbia

UPDATED

Washington District of Columbia 20057

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

Florida

UPDATED

Gainesville Florida 32610

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

UPDATED

Tampa Florida 33612

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Indiana

UPDATED

Goshen Indiana 46526

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

UPDATED

Indianapolis Indiana 46219

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

UPDATED

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

UPDATED

Indianapolis Indiana 46256

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

UPDATED

Munster Indiana 46321

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

Maryland

UPDATED

Baltimore Maryland 21201

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

UPDATED

Baltimore Maryland 21231

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

Massachusetts

UPDATED

Boston Massachusetts 02215

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Boston Massachusetts 02114

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Boston Massachusetts 02215

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Boston Massachusetts 02115

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating B-701, Docetaxel and placebo for the treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma, Urinary Bladder Disease or Urological Diseases

UPDATED

Rockland Massachusetts

Patients are needed to participate in a clinical research study of Avelumab to evaluate Solid Tumors

Michigan

UPDATED

Detroit Michigan 48202

A clinical research study of pembrolizumab for the treatment of Bladder Cancer, High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

Minnesota

UPDATED

Minneapolis Minnesota 55455

A clinical research study of pembrolizumab for the treatment of Bladder Cancer, High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

UPDATED

Minneapolis Minnesota 55455

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

UPDATED

Rochester Minnesota 55905

Patients are needed to participate in a clinical research study evaluating B-701, Docetaxel and placebo for the treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma, Urinary Bladder Disease or Urological Diseases

Missouri

UPDATED

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study evaluating B-701, Docetaxel and placebo for the treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma, Urinary Bladder Disease or Urological Diseases

UPDATED

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

Nebraska

UPDATED

Omaha Nebraska 68130

A clinical research study of pembrolizumab for the treatment of Bladder Cancer, High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

UPDATED

Omaha Nebraska 68130

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

Nevada

UPDATED

Las Vegas Nevada 89148

A clinical research study of pembrolizumab for the treatment of Bladder Cancer, High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

New Jersey

UPDATED

Hackensack New Jersey 07601

A clinical research study of pembrolizumab for the treatment of Bladder Cancer, High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)

UPDATED

Hackensack New Jersey 07601

Patients are needed to participate in a clinical research study of Placebo and Pembrolizumab to evaluate Urothelial Cancer or Bladder Cancer

UPDATED

New Brunswick New Jersey 08903

A clinical research study of pembrolizumab for the treatment of Bladder Cancer, High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)